CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via...

Journal of Hematology & Oncology 2020 / 12 Vol. 13; Iss. 1

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer

Wang, Jian, Zhang, Ruiguang, Lin, Zhenyu, Zhang, Sheng, Chen, Yaobing, Tang, Jing, Hong, Jiaxin, Zhou, Xiaoshu, Zong, Yan, Xu, Yingzhuo, Meng, Rui, Xu, Shuangbing, Liu, Li, Zhang, Tao, Yang, Kunyu, Do
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Hematology & Oncology
DOI:
10.1186/s13045-020-00926-x
Date:
December, 2020
File:
PDF, 3.51 MB
2020
Conversion to is in progress
Conversion to is failed